Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...

The prostaglandin evaluated in LL-BMT1 was bimatoprost, a well-established ... estate reinforces the company’s leadership in ophthalmic drug delivery and underscores its commitment to pioneering ...

MediPrint® Ophthalmics, a clinical-stage ophthalmic drug delivery company ... as a once-a-week solution to the comparator, 0.01% bimatoprost eye drop, offering a significant dosing advantage ...

The prostaglandin evaluated in LL-BMT1 was bimatoprost, a well-established treatment for lowering intraocular pressure ... This robust intellectual property estate reinforces the company’s leadership ...